Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 968 results for "ranbaxy"

RIL, BPCL, NTPC and Ranbaxy to see some action today

You are here ยป Indian-Commodity : Top News : 19-Nov 2013 Reliance Industries (RIL) will have to provide a bank guarantee of $135 million every quarter to get a higher price for natural gas from April 1 next year. The bank guarantee will be ... Indian-Commodity, 1 day ago

323 images for ranbaxy

VC Circle, 2 weeks ago
NDTV Profit, 2 weeks ago, 2 weeks ago
Reuters, 2 weeks ago
Reuters India, 2 weeks ago
Indiatimes, 1 week ago
DNA India, 1 week ago
Times of India, 1 week ago
Hindustan Times, 1 week ago
Hindustan Times, 1 week ago

Shanghvi all set to turn around Ranbaxy

The soft-spoken billionaire pharmaceutical tycoon Dilip Shanghvi is well known as Harry Potter fan. Shanghvi, who started Sun Pharma as a two man operation, now employs 14,000 employees, with products reaching over 40 countries. With the help of 13 acquisitions, over the last 22 years, Shanghvi has built Sun Pharmaceuticals into India’s largest pharmaceutical company, with consolidated sales of over Rs 27,500 crore. But with his latest acquisition of Ranbaxy, Shanghvi will perhaps need a ...
 Rediff.com2 days ago Shanghvi moves into top gear to turnaround Ranbaxy  Smart Investor5 days ago Dilip Shanghvi moves into top gear to turn around Ranbaxy  Rediff.com4 days ago

Sun Pharma drops 15% as its profit seen hit on Ranbaxy integration

As per the company's estimates, the consolidated revenues would remain flat or show a decline over FY15. Also the consolidated profits "may also be adversely impacted due to certain expenses/charges arising out of integration as well as remedial actions." ...
 DNA2 weeks ago Sun Pharma sees profit dent this fiscal on Ranbaxy integration  DNA2 weeks ago Integration with Ranbaxy may hit Sun Pharma profit  Financial Express2 weeks ago Sun Pharma warns on revenue, profit due to Ranbaxy takeover [Mint, New Delhi]  Bloomberg2 weeks ago

Open offer for Zenotech fails to meet target

The committee was formed to look into Sun Pharma's open offer following its acquisition of Ranbaxy Laboratories Ltd. Photo: Hemant Mishra/Mint Mumbai: An open offer by Sun Pharmaceutical Industries Ltd worth Rs. 20.23 crore to acquire a 28.16% ...
 Livemint.com1 week ago Sun Pharma's open offer to acquire stake fair: Zenotech committee  Livemint.com1 month ago India's Zenotech committee says Sun Pharma stake offer 'fair and reasonable'  FierceMedicalDevices1 month ago
India Infoline

Top Pharma news of the day

Sun Pharmaceutical Industries is cutting staff again as it digests the $3.2-billion acquisition of Ranbaxy Laboratories. Facing the axe this time are research and development staff, a move that comes a month after about 150 senior executives were asked to ...
 India Infoline5 days ago After acquiring Ranbaxy for $3.2 bn, Sun Pharma cuts staff in R&D division  Economic Times5 days ago More cuts as Sun Pharma pulls Ranbaxy into the fold  FiercePharmaManufacturing4 days ago After Cutting 150 Ranbaxy Laboratories (RANBAXY.BO) Execs, Sun Pharma (SUNPHARMA.NS) Takes the Ax to Some R&D Workers 7/30/2015  ClinicSpace5 days ago

Sun Pharmaceutical to discontinue certain non-strategic businesses of Ranbaxy

SENSEX 28434.66 14.54 0.05% NIFTY 8606.95
 Finalaya.com2 weeks ago Sun may divest Ranbaxy's non-strategic businesses  Hindu Business Line2 weeks ago India : CERTAIN non-strategic businesses of Ranbaxy to be discontinue by Sun Pharmaceutical [TendersInfo (India)]  Pharmacy Choice1 week ago Sun may divest Ranbaxys non-strategic businesses  FirstWord Pharma2 weeks ago
Times of India

Sun Pharma mulling options of exiting Ranbaxy's "low-margin" overseas geographies

We encourage visitors to register on IIFL. Registering on the site is absolutely Free and offers you the following benefits. Free Portfolio of Equity and Assets Exclusive E-newsletter Post Comments and Share Feedback Your Personal Page Access Premium Services ...
 India Infoline1 week ago Sun Pharma may exit part of Ranbaxy business to push growth  Economic Times1 week ago Sun Pharma may shed part of Ranbaxy biz to push growth  Times of India1 week ago

Sun Pharma tumbles as Ranbaxy merger cost to impact revenues, profit

Sun Pharmaceutical Industries , an international, integrated, speciality pharmaceutical company, witnessed a sharp fall in share price on Tuesday after the company said that the company's FY16 revenue could remain flat or show a decline over FY15 ...
 MyIris2 weeks ago Sun Pharma tumbles as Ranbaxy integration charges to impact revenues, profit  Myiris2 weeks ago

Dilip Shanghvi loses over $5 billion in networth as Ranbaxy guidance takes its toll on Sun Pharma

Sun Pharma's stock fell almost 15% on Tuesday, after the company said it expects to take a hit on its profit due to its ongoing integration with Ranbaxy. As a result, the m-cap fell about Rs 34,000 crore, leading to a loss of $2.9 billion (around Rs 18,438 ...
 DNA1 week ago Shanghvi drops axe, many more may fall at Ranbaxy  Times of India1 month ago Dilip Shanghvi drops the axe, many more may fall at Ranbaxy  Economic Times1 month ago

Sun Pharma in process to integrate Ranbaxy, overhauls combined global operations

By Vikas Dandekar MUMBAI: One of Ranbaxy Laboratories' crown jewels is unlikely to enjoy the same pride of place under the new owner. Sun Pharmaceutical Industries may relegate the manufacturing facility at Paonta Sahib in Himachal Pradesh for ...
 Economic Times1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy
Get updated on latest news & your favorite topics right in your inbox!
More     Less